COMPANY
GSNO Therapeutics
Funding and NIH signals
- NIH award NIH awarded $303K (SBIR Phase I 1R43EY039156-01, new, notice Sep 17, 2026). NIH RePORTER 1R43EY039156-01 (Sep 17, 2026)
Evidence (1 event)
- Sep 17, 2026 · NIH RePORTER 1R43EY039156-01
Organization: GSNO THERAPEUTICS, INC.; City/State: SHELTON, WA; Project number: 1R43EY039156-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 303035; Administering IC: National Eye Institute; Project title: Inhibition of Optic Nerve Degeneration; Organization type: Domestic For-Profits
- Sep 17, 2026 · NIH RePORTER 1R43EY039156-01